share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144：拟议出售证券

SEC announcement ·  03/04 17:43
Moomoo AI 已提取核心信息
Arcutis Biotherapeutics, Inc. officer Patrick Burnett is set to sell 4,782 shares of common stock on 03/04/2024, as per the latest filing. The shares to be sold have an aggregate market value of $53,181. Burnett acquired these shares through restricted stock vesting on two separate dates, with 3,855 shares vested on 03/01/2024 and an additional 927 shares on 03/03/2024, both from Arcutis Biotherapeutics. This transaction follows a previous sale of 1,325 shares in the past three months, which had gross proceeds of $4,691.
Arcutis Biotherapeutics, Inc. officer Patrick Burnett is set to sell 4,782 shares of common stock on 03/04/2024, as per the latest filing. The shares to be sold have an aggregate market value of $53,181. Burnett acquired these shares through restricted stock vesting on two separate dates, with 3,855 shares vested on 03/01/2024 and an additional 927 shares on 03/03/2024, both from Arcutis Biotherapeutics. This transaction follows a previous sale of 1,325 shares in the past three months, which had gross proceeds of $4,691.
根据最新文件，Arcutis Biotherapeutics, Inc.高管帕特里克·伯内特定于2024年4月3日出售4,782股普通股。待售股票的总市值为53,181美元。伯内特在两个不同的日期通过限制性股票归属收购了这些股票，其中3,855股于2024年1月3日归属，另有927股股票于2024年3月3日归属，均来自Arcutis Biotherapeutics。该交易是在过去三个月中出售1,325股股票之后进行的，总收益为4,691美元。
根据最新文件，Arcutis Biotherapeutics, Inc.高管帕特里克·伯内特定于2024年4月3日出售4,782股普通股。待售股票的总市值为53,181美元。伯内特在两个不同的日期通过限制性股票归属收购了这些股票，其中3,855股于2024年1月3日归属，另有927股股票于2024年3月3日归属，均来自Arcutis Biotherapeutics。该交易是在过去三个月中出售1,325股股票之后进行的，总收益为4,691美元。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息